UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  December 4, 2003

 


 

VERTEX PHARMACEUTICALS INCORPORATED

(Exact name of registrant as specified in its charter)

 

MASSACHUSETTS

 

000-19319

 

04-3039129

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.

 

130 Waverly Street
Cambridge, Massachusetts  02139

(Address of principal executive offices) (Zip Code)

 

(617) 444-6100

Registrant’s telephone number, including area code:

 

 



 

Item 9.   Regulation FD Disclosure.

 

On December 4, 2003, Vertex Pharmaceuticals Incorporated issued a press release to announce the sale of certain instrumentation assets of Vertex’s subsidiary Aurora Instruments LLC to Aurora Discovery, Inc., and updating its 2003 full-year financial guidance.  A copy of this press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

VERTEX PHARMACEUTICALS INCORPORATED
(Registrant)

 

 

 

 

Date:  December 5, 2003

 /s/ Ian F. Smith

 

Ian F. Smith

 

Senior Vice President and Chief Financial Officer

 

EXHIBIT INDEX

 

The following exhibits are filed as part of this current report on Form 8-K:

 

Exhibit
No.

 

Description

99.1

 

Press Release of Vertex Pharmaceuticals Incorporated dated December 4, 2003 entitled “Telegraph Hill Partners Acquires Instrumentation Assets of Aurora Instruments LLC from Vertex Pharmaceuticals.”

 

2